INV-05 platform (InVasc)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameINV-05 platform (InVasc)
Drug Alias Namecardiac therapy (InVasc)INV-55-05INV-55-06
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRaynaud DiseaseHypertensionAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRaynaud DiseaseHypertensionAngina Pectoris

Other Information

ATC CodeN/A
Related LinksN/A